Biogen Idec Quote Page (BIIB)

DJIA	12,454.83	-74.92	-0.60%
NASDAQ	2,837.53	-1.85	-0.07%
S&P 500	1,317.82	-2.86	-0.22%

7 Biotech Stocks to Add to Your Portfolio

5/26/2012 by InvestorPlace

Biogen shares poised to advance further, says BMO Capital

5/24/2012 by Theflyonthewall.com

Biogen Idec (BIIB): TYSABRI Product Monograph Updates Approved In Canada

5/23/2012 by iStockAnalyst

Health Canada approves updates to Tysabri labeling

5/23/2012 by Theflyonthewall.com

Health Canada Approves Updates to TYSABRI® (natalizumab) Product Monograph to Include Anti-JC Virus Antibody Status

5/23/2012 by PR Newswire

22 Biopharma Stocks With Breakout Potential in 2012

5/22/2012 by TheStreet.com

The Zacks Analyst Blog Highlights: Dr. Reddy's Laboratories, Bristol-Myers Squibb, Teva Pharmaceutical, Biogen Idec and Elan

5/21/2012 by PR Newswire

The Zacks Analyst Blog Highlights: Dr. Reddy's Laboratories, Bristol-Myers Squibb, Teva Pharmaceutical, Biogen Idec and Elan - Press Releases

5/21/2012 by Zacks Investment Research

Critical Alerts For Qualcomm, Simon Property, Silver Wheaton, Biogen Idec, and Nu Skin Released By InvestorsObserver

5/18/2012 by PR Newswire

Tough Market? Not for Defensive Stocks

5/18/2012 by InvestorPlace

New Analysis of Risk Stratification for TYSABRI® Published in New England Journal of Medicine

5/18/2012 by PharmiWeb.com - UK

New Analysis of Risk Stratification for TYSABRI® Published in New England Journal of Medicine

5/17/2012 by Business Wire

Biotech ETFs Hitting Highs (IBB, XBI, PBE, AMGN, BIIB)

5/17/2012 by Investopedia

While U.S. Patients Report High Levels of Satisfaction with Current DMAs, Switching Interest is Highest among Patients for Sanofi / Genzyme’s Teriflunomide and Biogen Idec’s BG-12, According to a Recent BioTrends Report

5/17/2012 by PharmiWeb.com - UK

While U.S. Patients Report High Levels of Satisfaction with Current DMAs, Switching Interest is Highest among Patients for Sanofi / Genzyme’s Teriflunomide and Biogen Idec’s BG-12, According to a Recent BioTrends Report

5/17/2012 by Business Wire

Zacks Bull and Bear of the Day Highlights: Eastman Chemical, Kirkland's, Biogen Idec, Abbott, Novartis

5/14/2012 by PR Newswire

Following the Release of Detailed Results from the CONFIRM Study at the 64th Annual Meeting of the American Academy of Neurology, 90 Percent of Surveyed U.S. Neurologists Report Willingness to Prescribe Biogen Idec’s BG-12

5/14/2012 by PharmiWeb.com - UK

Zacks Bull and Bear of the Day Highlights: Eastman Chemical, Kirkland's, Biogen Idec, Abbott, Novartis - Press Releases

5/14/2012 by Zacks Investment Research

Biogen: New AVONEX dosing innovations for people with MS now available

5/14/2012 by Theflyonthewall.com

New AVONEX® Dosing Innovations for People with Multiple Sclerosis Now Available in US

5/14/2012 by Business Wire

Following the Release of Detailed Results from the CONFIRM Study at the 64th Annual Meeting of the American Academy of Neurology, 90 Percent of Surveyed U.S. Neurologists Report Willingness to Prescribe Biogen Idec’s BG-12

5/14/2012 by Business Wire

Biogen management to meet with Lazard Capital

5/10/2012 by Theflyonthewall.com

US and EU Regulatory Authorities Accept Oral BG-12 Marketing Applications for Review

5/10/2012 by PharmiWeb.com - UK

Healthcare Stocks Come Alive Amid Market Woes

5/9/2012 by Investopedia

Biogen Idec (BIIB) PT Lifted To $148 By UBS Securities On Pipeline Optionality, 'Buy' Maintained

5/9/2012 by iStockAnalyst

US, EU regulators accept oral BG-12 marketing applications for review

5/9/2012 by Theflyonthewall.com

US and EU Regulatory Authorities Accept Oral BG-12 Marketing Applications for Review

5/9/2012 by Business Wire

Top Analyst Upgrades & Downgrades (ACM, ALNY, BIIB, BP, COF, SNP, CTSH, EA, EPB, ERJ, F, LPX, MFC, MM, RAX, SYNC, VRTX, WYNN)

5/8/2012 by 24/7 Wall Street

Biogen Idec to Present at the Deutsche Bank 37th Annual Healthcare Conference

5/3/2012 by PharmiWeb.com - UK

Company news: Biogen Idec and Targacept

5/1/2012 by Medical Marketing & Media (MM&M)

Biogen Idec's CEO Discusses Q1 2012 Results - Earnings Call Transcript

5/1/2012 by Seeking Alpha

Pre-market Movers For May 1 (SIRI, PFE, IPSU, SHLD, PFCB, CAR, PLXT, BIIB, CEBK)

5/1/2012 by RTTNews

Biogen Idec Lifts Annual Forecast Even As Q1 Misses View

5/1/2012 by RTTNews

Biogen says sees no major deviations from plans for uses of cash